Brief: Black Diamond Therapeutics -First Patients Dosed In Phase 1 Clinical Trial Expansion Cohorts Evaluating Bdtx-1535
11/09/2023 13:36
Sept 11 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS ANNOUNCES FIRST PATIENTS DOSED
IN
PHASE 1 CLINICAL TRIAL EXPANSION COHORTS EVALUATING BDTX-1535 IN
PATIENTS WITH INTRINSIC DRIVER AND ACQUIRED RESISTANCE EGFR
MUTATION POSITIVE NON-SMALL CELL LUNG CANCER
Source text for Eikon: ID:nGNX3X0hhB
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))